Sign In
Buy ECOR
$6.09
-0.205 (-3.26%)
At Close: Jul 31, 2026
Ecora Resources boosted by 'best' drill results yet at Patterson Corridor East uranium project
03:24am, Tuesday, 02'nd Dec 2025
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) has reported new assay results from operator NexGen Energy showing the highest-grade mineralisation so far at the Patterson Corridor East uranium
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
04:05pm, Monday, 10'th Nov 2025
ROCKAWAY, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at
electroCore, Inc. (ECOR) Q3 2025 Earnings Call Transcript
09:51pm, Wednesday, 05'th Nov 2025
electroCore, Inc. ( ECOR ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Daniel Goldberger - CEO & Director Thomas Errico - Founder & Independent Chairman Joshua Lev - Chief
electroCore, Inc. (ECOR) Reports Q3 Loss, Beats Revenue Estimates
07:36pm, Wednesday, 05'th Nov 2025
electroCore, Inc. (ECOR) came out with a quarterly loss of $0.4 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $0.31 per share a year ago.
electroCore Announces Third Quarter 2025 Financial Results
04:05pm, Wednesday, 05'th Nov 2025
Net sales of $8.7 million increased 33% vs. Q3 2024; YTD net sales of $22.8 million increased 26% vs. first nine months of 2024
Ecora sees strong Q3 base metals performance - ICYMI
07:52am, Saturday, 01'st Nov 2025
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) CEO Marc Bishop Lafleche talked with Proactive about the company's record Q3 performance and updated full-year guidance. The update revealed a 112
Analysts Estimate electroCore, Inc. (ECOR) to Report a Decline in Earnings: What to Look Out for
11:10am, Wednesday, 29'th Oct 2025
electroCore (ECOR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025
08:11am, Thursday, 23'rd Oct 2025
ROCKAWAY, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial result
Ecora: Copper royalty play gains shine from new deal
09:30am, Wednesday, 15'th Oct 2025
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) has edged closer to a long-awaited payday from its stake in the Santo Domingo copper project, after...
Ecora: Copper royalty play gains shine from new deal
08:36am, Wednesday, 15'th Oct 2025
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) has edged closer to a long-awaited payday from its stake in the Santo Domingo copper project, after Capstone Copper confirmed a $360m investment f
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
04:05pm, Friday, 03'rd Oct 2025
ROCKAWAY, N.J., Oct. 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Jennifer H
ROCKAWAY, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of a peer-reviewed
electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium
08:00am, Monday, 29'th Sep 2025
ROCKAWAY, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCore™ Sapphire (nVNS) h
electroCore's Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire's 2025 Sleep Awards
08:00am, Monday, 22'nd Sep 2025
ROCKAWAY, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its Truvaga™ Plus handheld v
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
04:05pm, Wednesday, 10'th Sep 2025
ROCKAWAY, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Andy Brow
